Doximity launches Doximity Dialer Video- a free telehealth app for providers

Nilesh Kumbharkar | May 06, 2020

Doximity launches Doximity Dialer Video- a free telehealth app for providers
  • Doximity launched Doximity Dialer Video, a telehealth app that enables doctors to video call their patients on any smartphone.

  • Doximity's telehealth solution is HIPAA-secure and doesn't require any extra apps or sign up for software.

  • Doximity Dialer is the company's secure voice calling feature that enables doctors to call patients using their cell phone while setting the caller ID to their hospital or office line.


Professional medical network Doximity is expanding into the telemedicine market.

The company launched Doximity Dialer Video, a telehealth app that enables doctors to video call their patients on any smartphone.

Doximity's telehealth solution is HIPAA-secure and doesn't require patients or doctors to download any extra apps or sign up for software, the company said.

The company has seen a huge spike in engagement on its platform since the onset of the COVID-19 pandemic, said Amit Phull, M.D., Doximity's vice president of strategy and insights.


Doximity was built from the ground up with security and privacy as the top priority, Calls made through Dialer Video are HIPAA-compliant, encrypted, and easy to use. It also works with any health system’s existing suite of telemedicine technologies. For the patient, it works with any smartphone and there are no extra downloads or sign-in required. Doctors can just send a link and connect with their patients instantly.

- Amit Phull, M.D., Doximity's vice president of strategy and insights.

oximity Dialer is the company's secure voice calling feature that enables doctors to call patients using their cell phone while setting the caller ID to their hospital or office line.

"Doctors are relying on Doximity more than ever during this critical time to be efficient, stay up to date with the latest news and research, and to connect with patients safely and securely," Phull said.

As more physicians work from home or turn to virtual care to treat patients, they need tools that work for everyone on their care team and can be rapidly adopted. Close to half of doctors are now using telehealth to treat patients as the COVID-19 pandemic changes practice patterns and how physicians deliver care, according to a survey from the Physicians Foundation.


Read More: UC HOSPITAL SYSTEM TO GRADUALLY RESTART ELECTIVE PROCEDURES CANCELED DUE TO COVID-19


Doximity launched the new telehealth app to meet the needs of physicians for a simple telemedicine tool, the company said.

The demand for telehealth solutions has soared during the pandemic, and the field is now crowded with major industry players like Teladoc and Amwell and new telemedicine solutions that have been released during the pandemic.

Federal health regulators also have waived some restrictions to enable doctors to use consumer-facing tools like Skype and Zoom.

But many mainstream platforms are not HIPAA-compliant and are challenging for patients and their doctors to use, Phull said.

"Other tools proved to be insecure and represented a risk to patient privacy. We’re always asking our physician members for feedback on how we can better serve their clinical needs. Our members told us they wanted an easy-to-use telemedicine tool—something that was secure and protected their privacy, and that of their patients. They also wanted a tool that was simple for patients to use," he said.

About 70% of U.S. physicians already use the Doximity platform every day, according to the company.


Doximity was built from the ground up with security and privacy as the top priority, Calls made through Dialer Video are HIPAA-compliant, encrypted, and easy to use. It also works with any health system’s existing suite of telemedicine technologies. For the patient, it works with any smartphone and there are no extra downloads or sign-in required. Doctors can just send a link and connect with their patients instantly.

- Amit Phull, M.D., Doximity's vice president of strategy and insights.


The Doximity Dialer Video tool includes Custom CallerID which enables physicians to set the CallerID to their hospital or office line and integrates with Epic Haiku, the health IT vendor's mobile electronic health record (EHR) app. 

The platform also complies with the Health Insurance Portability and Accessibility Act (HIPAA) requirements as patient calls are encrypted, kept private, and never recorded, the company said.


Read More: CHANGE HEALTHCARE BUYS BACK PHARMACY UNIT FOR $213M, SELLS ANALYTICS DIVISION TO KAUFMAN HALL
 

Munir Janmohamed, M.D., medical director of advanced heart failure at Dignity Health Sacramento, said physicians need efficient telemedicine tools to do virtual visits from their smartphones.

"It’s reliable, secure and a very simple solution for my patients. It’s incredibly helpful to be able to see them through a video call. This is reassuring for patients and helps me make a better clinical assessment of how they’re doing," Jonmohamed said in a statement.

In response to the COVID-19 crisis, Dialer Video is available for free through January 2021.
 

About Doximity

Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest medical professional network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health.

Spotlight

Watch AMA President David O. Barbe, MD, MHA, discuss some of the biggest issues in health care for the coming year.


Other News

HEALTH TECHNOLOGY

PulsePoint Releases Next Generation Health Media Platform With Advanced Automation And AI

PulsePoint | July 06, 2021

PulsePoint, a technology company revolutionizing health decision-making in real-time, today announced the next generation launch of its digital media buying platform, Life by PulsePoint™. Its enhanced AI and automation simplifies and supercharges the media planning, activation, and optimization processes. Designed for the self-serve programmatic trader, these updates promote efficiencies and surface predictive and in-flight campaign analytics for quick strategic decisioning to yield higher media return on investment. Built upon PulsePoint's extensive data foundation, Genome™, that proactively uses microdata to capture attention when intent is signal...

Read More

HEALTH TECHNOLOGY

Future Health announced today that it has completely digitalised its annual in-person event at ExCeL London

Future Health | March 02, 2021

Future Health has completely rebranded during lockdown, and the flagship face-to-face event Future Health Innovations at ExCeL is now complemented by a global virtual conference series, under the brand UK Health Week. Free for delegates to attend, it is CPD and CME accredited. Participants will be able to connect, meet buyers and partake in cross border purchasing, education and deal making, enabling an increased ROI and profitable encounters with its AI powered networking software. Further Health Weeks are being rolled out around the world over the course of the coming months, and will be territory specific. Dawn Barclay-Ross, Event Director commented: “I think ...

Read More

HEALTH TECHNOLOGY

L2Mtech GmbH Receives CE Mark Approval on 6(SIX) products for Cardiovascular and Endovascular Applications

L2Mtech | February 17, 2021

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent System for Endovascular Applications CE Mark Approval for FlexiTrack 018™, Peripheral Balloon Catheter for Endovascular Applications CE Mark Approval for

Read More

CMS to pay providers via MIPS for participating in COVID-19 drug treatment trials

CMS | April 21, 2020

Clinicians can earn a credit via the Merit-based Incentive Payment System (MIPS) if they participate in a clinical trial and report clinical information on COVID-19, the Trump administration announced late Monday. The Centers for Medicare & Medicaid Services (CMS) said Monday that the goal of the new credit is to provide data that will be vital to making treatments to combat the virus. “The best scientific and medical minds in the world are working night and day to find treatments to combat coronavirus,” CMS Administrator Seema Verma said in a statement Monday. “But without solid data, their efforts are liable to run against a brick wall.”...

Read More

Spotlight

Watch AMA President David O. Barbe, MD, MHA, discuss some of the biggest issues in health care for the coming year.

Resources

Events